Hjem › Merkelcellekarcinom › Texas › Houston
Kliniske studier for Merkelcellekarcinom i Houston, TX
6 studier for Merkelcellekarcinom søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RekruttererFase 2
- M D Anderson Cancer Center, Houston
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
RekruttererFase 2
- M D Anderson Cancer Center, Houston
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RekruttererFase 2/3
- The University of Texas MD Anderson Cancer Center, Houston
Merkelcellekarcinom-studier i andre byer
- Boston, MA5 studier
- Tampa, FL4 studier
- New York City, NY4 studier
- San Antonio, TX4 studier
- Seattle, WA3 studier
- Queens, NY3 studier
- Jacksonville, FL3 studier
- Pittsburgh, PA3 studier
- Miami, FL3 studier
- Arlington, VA3 studier
- Los Angeles, CA3 studier
- St. Louis, MO3 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.